An investigational cell therapy being evaluated at Health has been granted fast-track designation by the U.S. Food and Drug Administration to help patients with oropharyngeal dysphagia ...

“Our CB-SCs can target different compartments of the immune system, educating and correcting their dysfunctions at a fundamental level,” says Dr. Zhao. “This therapy has the potential to revolutionize ...

The researchers analyzed gene and protein expression, along with lipid profiles, in the bone marrow of mice whose Elovl2 gene ...

The U.S. Food and Drug Administration has granted regenerative medicine advanced therapy (RMAT) designation to Fate's FT819 ...

Forward Healthy Lifestyles offers non-surgical, regenerative therapies that support relief of chronic joint pain, restore mobility, and en ...

Shares of gene therapy developer uniQure N.V. (QURE) shot up 41% on Thursday afternoon after it announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation ...

Qure's AMT-130 receives FDA Breakthrough Therapy designation for Huntington's disease, adding to Fast Track, RMAT, and Orphan ...

Scientists at the University of California, Riverside, have discovered how adult stem cells retain their regenerative power.

Nuo Therapeutics, Inc. is a commercial-stage medical device company pioneering biodynamic therapies that harness the body’s innate healing abilities. The company’s flagship product, the Aurix System, ...

The Loan has minimum fixed interest of $400,000 for the first six months and bears interest at 14.25% per annum thereafter. The Loan principal is due on the Maturity Date, and interest is due and ...

The global bone regeneration market is poised for remarkable growth, with projections estimating its value to surge from USD 5,380.75 million in 2023 to USD 7,827.8 million by 2033. This growth is ...